Studies on human brains have evaluated the levels or activity of total GSK-3β protein in the prefrontal cortex in mood disorders, including depression (22, 42), and increasing evidence suggests that inhibition of GSK-3β might contribute to antidepressant activity (43). Here, GSK3B is linked to major depressive disorder.